Contact this trialFirst, we need to learn more about you.
Small Molecule
ONC201 for Glioblastoma
Recruiting1 awardPhase 2
Minneapolis, Minnesota
This trial will study the effects of a drug on adults with glioblastoma. Up to 36 patients will be treated with oral ONC201 twice weekly.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service